BlackRock »

SPDR S&P Pharmaceuticals shares owned by BlackRock

Quarter-by-quarter ownership of SPDR S&P Pharmaceuticals (XPH) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in SPDR S&P Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Pharmaceuticals held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Pharmaceuticals by BlackRock

Quarter filed Position value Share count Share price at filing
2026-06-30 $99k 1.5k 66.27

More positions owned by BlackRock

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Micron Technology (MU)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for BlackRock

Top funds holding SPDR S&P Pharmaceuticals

Bank of America Corporation
CWM
Wells Fargo & Company
Kingsview Wealth Management
Morgan Stanley
Envestnet Asset Management
First Citizens Bank & Trust
Envestnet Portfolio Solutions
LPL Financial
Branch Banking & Trust Company
Measured Wealth Private Client Group
Private Advisor
UBS Group
Susquehanna International
Citigroup

View all funds holding SPDR S&P Pharmaceuticals